NEW YORK (GenomeWeb) – NeoGenomics today reported an 18 percent year-over-year increase in second quarter revenues, including a 12 percent rise in testing revenue. 

For the three months ended June 30, the Ft. Myers, Florida-based cancer genetics testing company posted $24.3 million in revenues, up from $20.7 million in the year-ago quarter but falling shy of analysts' consensus estimate of $25.3 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.